ALAMAR BIOSCIENCES INC · held by 1 fund · data as of 2026-06-03
Sector
Healthcare
Industry
Medical Devices
Market cap
$1.44B
Price
$20.98
12-mo
-4.60%
Held by
1 fund
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics. The company's offering is utilized in research…